Despite the contradicting view of the European Association of Urology (uroweb.org/guideline/prostate-cancer/#5), low specificity of PSA calls for a reliable, highly specific, and sensitive alternative for diagnosis and staging of PCa. This evidence concerns the gene KLK3 and posterior cortical atrophy.